Viewing Study NCT02179151


Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2026-02-23 @ 12:22 PM
Study NCT ID: NCT02179151
Status: TERMINATED
Last Update Posted: 2017-01-26
First Post: 2014-06-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Sponsor: Zafgen, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prader-Willi Syndrome View
None Obesity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Prader-Willi Syndrome View
None Obesity View
None Hyperphagia View